A resident takes a Covid-19 test as part of a mass screening programme in Hong Kong, on September 1. Photo: Xinhua A resident takes a Covid-19 test as part of a mass screening programme in Hong Kong, on September 1. Photo: Xinhua
A resident takes a Covid-19 test as part of a mass screening programme in Hong Kong, on September 1. Photo: Xinhua

Mainland-listed Hybribio involved in Hong Kong’s Covid-19 mass testing scheme eyes expansion

  • Hybribio, the parent of Hong Kong Molecular Pathology Diagnostic Centre, said the volume of work was less than anticipated
  • DNA samples from Hong Kong tests have not been sent to the mainland China, said director Kun Tit Sang

Topic |   Coronavirus pandemic
A resident takes a Covid-19 test as part of a mass screening programme in Hong Kong, on September 1. Photo: Xinhua A resident takes a Covid-19 test as part of a mass screening programme in Hong Kong, on September 1. Photo: Xinhua
A resident takes a Covid-19 test as part of a mass screening programme in Hong Kong, on September 1. Photo: Xinhua
READ FULL ARTICLE